Publisher
Springer International Publishing
Reference53 articles.
1. Charlson FJ, Baxter AJ, Dua T, Degenhardt L, Whiteford HA, Vos T. Excess mortality from mental, neurological and substance use disorders in the Global Burden of Disease Study 2010. Epidemiol Psychiatr Sci. 2015;24(2):121–40.
2. Murphy PS, Patel N, McCarthy TJ. Has molecular imaging delivered to drug development? Philos Trans A Math Phys Eng Sci. 2107;2017:375.
3. NIH CNS Radiotracer Table [Available from: https://www.nimh.nih.gov/research/research-funded-by-nimh/therapeutics/cns-radiotracer-table.shtml.
4. Aarthy M, Panwar U, Selvaraj C, Singh SK. Advantages of structure-based drug design approaches in neurological disorders. Curr Neuropharmacol. 2017;15(8):1136–55.
5. Smoller JW, Andreassen OA, Edenberg HJ, Faraone SV, Glatt SJ, Kendler KS. Psychiatric genetics and the structure of psychopathology. Mol Psychiatry. 2019;24(3):409–20.